| Efficacy of low-dose tamsulosin on lower urinary tract symptoms suggestive of benign prostatic hyperplasia : a nonblind multicentre korean study. | |
| | |
MedLine Citation:
|
PMID: 17516689 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
OBJECTIVE: To evaluate the efficacy and tolerability of tamsulosin 0.2mg once daily in Korean patients with lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH), who were treated for up to 1 year. MATERIALS AND METHODS: Of the 211 patients from six urology outpatient centres who participated in this investigation, 146 patients were evaluable. Tamsulosin 0.2 mg/day was administered orally in a nonblind design for a 1-year period. The primary efficacy parameters were improvement in the total, obstructive and irritative International Prostate Symptom Score (IPSS), measured at baseline and at weeks 12, 24, 36 and 52, and in the maximal urinary flow rate (Qmax) measured at baseline and at weeks 24 and 52. The secondary efficacy parameters were a decrease of >/=30% in IPSS, and an increase in Qmax of >/=30% from baseline. Changes in parameters between baseline and 52 weeks were assessed using Student's paired t-test. RESULTS: Statistically significant, gradual improvements in all efficacy parameters were observed over the 1-year period. Tamsulosin 0.2 mg/day resulted in a mean reduction of 41.1% in total IPSS (p < 0.001) and a mean increase of 4.56 mL/sec in Qmax at 52 weeks (p < 0.001). Tamsulosin was well tolerated; adverse events occurred in 6.2% of patients and there were no withdrawals as a result of adverse events. There were no significant changes in blood pressure or pulse rate during the study. CONCLUSIONS: One-year treatment with tamsulosin 0.2 mg/day in Korean patients with suspected BPH was well tolerated and effective in improving LUTS and urinary flow. The effect on symptoms was apparent after 12 weeks of treatment, and symptom improvement was observed for up to 1 year. |
| | |
Authors:
|
Choal Hee Park; Hyuk Soo Chang; Bong Ryul Oh; Hyung Jee Kim; Chong Koo Sul; Sung Kwang Chung; Se Il Jung |
Related Documents
:
|
18025849 - Outcomes of 80 w ktp laser vaporization of the large prostate. 15947629 - Holmium laser bladder neck incision versus holmium enucleation of the prostate as outpa... 20092849 - Photoselective prostatic vaporization for bladder outlet obstruction: 12-month evaluati... 16903819 - Ktp laser versus transurethral resection: early results of a randomized trial. 10233489 - A prospective randomized controlled trial of hybrid laser treatment or transurethral re... 10934809 - Transrectal ultrasonographic findings in patients with hemospermia. 19308589 - Financial analysis of circumferential fusion versus posterior-only with thoracic pedicl... 20972569 - "number needed to read"-how to facilitate clinical trials in mr-angiography. 2123079 - Long-term predictors of outcome in abstinent alcoholic men. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Clinical drug investigation Volume: 24 ISSN: 1173-2563 ISO Abbreviation: Clin Drug Investig Publication Date: 2004 |
Date Detail:
|
Created Date: 2007-05-22 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9504817 Medline TA: Clin Drug Investig Country: New Zealand |
Other Details:
|
Languages: eng Pagination: 41-7 Citation Subset: - |
Affiliation:
|
Department of Urology, Keimyung University School of Medicine, Daegu, Korea. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Ceftriaxone versus Other Antibiotics for Surgical Prophylaxis : A Meta-Analysis.
Next Document: Safety and tolerability of volplex((r)) in elective surgery.